Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Harrow Inc (HROW)

Harrow Inc (HROW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Harrow Inc 1A Burton Hills Blvd. Suite 200 Nashville TN 37215 USA

www.harrow.com Employees: 373 P: 615-733-4730

Sector:

Medical

Description:

Harrow Inc. is an eyecare pharmaceutical company. It engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products principally for the U.S. market. Harrow Inc., formerly known as Harrow Health Inc., is based in NASHVILLE, Tenn.

Key Statistics

Overview:

Market Capitalization, $K 1,239,759
Enterprise Value, $K 1,410,009
Shares Outstanding, K 37,230
Float, K 32,141
% Float 86.33%
Short Interest, K 6,245
Short Float 16.78%
Days to Cover 3.90
Short Volume Ratio 0.67
% of Insider Shareholders 13.67%
% of Institutional Shareholders 72.76%

Financials:

Annual Sales, $ 272,300 K
Annual Net Income, $ -5,140 K
Last Quarter Sales, $ 89,090 K
Last Quarter Net Income, $ 6,630 K
EBIT, $ 30,520 K
EBITDA, $ 54,250 K

Growth:

1-Year Return 27.05%
3-Year Return 45.41%
5-Year Return 372.34%
5-Year Revenue Growth 457.19%
5-Year Earnings Growth 560.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.26 on 03/02/26
Next Earnings Date 05/14/26
Earnings Per Share ttm 0.45
EPS Growth vs. Prev Qtr -21.21%
EPS Growth vs. Prev Year 4.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-5 on 02/08/13

HROW Ratios

Ratio
Price/Earnings ttm 75.18
Price/Earnings forward 40.11
Price/Earnings to Growth N/A
Return-on-Equity % 36.51%
Return-on-Assets % 5.06%
Profit Margin % -1.89%
Debt/Equity 4.67
Price/Sales 4.63
Price/Cash Flow 40.94
Price/Book 25.16
Book Value/Share 1.41
Interest Coverage -0.94
60-Month Beta 0.05
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.